Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model

Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model

Pancreatic cancer (PC) represents an intriguing topic for researchers. To date, the prognosis of metastasized PC is poor with just 7% of patients exceeding a five-year survival period. Thus, molecular modifications of existing drugs should be developed to change the course of the disease. Our previo...

Full description

Saved in:
Bibliographic Details
Main Authors: Giamaica Conti, Martina Pitea, Riccardo Ossanna, Roberta Opri, Giada Tisci, Elisabetta Falvo, Giulio Innamorati, Esther Ghanem, Andrea Sbarbati, Pierpaolo Ceci, Giulio Fracasso
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
targeted therapy
pancreatic cancer
human ferritin
transferrin receptor (CD71)
mitoxantrone
Biology (General)
QH301-705.5
Online Access:https://doaj.org/article/39a8cae188c14ca3b763e71c4222e23c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/39a8cae188c14ca3b763e71c4222e23c

Similar Items